The strategic management literature has developed several typologies and taxonomies concerning large, established firms. Yet, to date, no study has attempted to classify newly formed organizations based on their strategic intent. The study of biotechnology firms undergoing an initial public offering presents a rare opportunity to study recently formed organizations within an emerging industry. Drawing from the strategic management and entrepreneurship literature, the present study offers a typology for these firms.

You do not currently have access to this chapter.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.